+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Salivary Gland Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767985
  • Report
  • April 2019
  • Region: Global
  • 96 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Bayer AG
  • Bristol-Myers Squibb Co
  • Daiichi Sankyo Co Ltd
  • F. Hoffmann-La Roche Ltd
  • MORE
The global clinical trial report- “2019 Salivary Gland Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Salivary Gland Cancer. It presents in-depth analysis of Salivary Gland Cancer clinical trials across markets and companies. The research work is for providing complete understanding into trends in Salivary Gland Cancer.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Salivary Gland Cancer clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Salivary Gland Cancer

The research work is prepared through extensive and continuous research on Salivary Gland Cancer trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Salivary Gland Cancer patients are identified
  • The report includes panorama of Salivary Gland Cancer clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Salivary Gland Cancer clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Bayer AG
  • Bristol-Myers Squibb Co
  • Daiichi Sankyo Co Ltd
  • F. Hoffmann-La Roche Ltd
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Salivary Gland Cancer Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Salivary Gland Cancer Clinical Trials by Region
2.2.2 Average Enrollment of Salivary Gland Cancer Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Salivary Gland Cancer Treatment, 2019

3. Region wise Salivary Gland Cancer Clinical Trials
3.1 Asia Pacific Salivary Gland Cancer Clinical Trials by Country
3.2 Europe Salivary Gland Cancer Clinical Trials by Country
3.3 North America Salivary Gland Cancer Clinical Trials by Country
3.4 Middle East and Africa Salivary Gland Cancer Clinical Trials by Country
3.5 South and Central America Salivary Gland Cancer Clinical Trials by Country

4. Salivary Gland Cancer Clinical Trial Trends
4.1 Start Year wise Salivary Gland Cancer Clinical Trials
4.2 Phase wise Salivary Gland Cancer Clinical Trials
4.3 Trial Status wise Salivary Gland Cancer Clinical Trials
4.4 Trial Type wise Salivary Gland Cancer Clinical Trials

5. Salivary Gland Cancer Average Enrollment Trends
5.1 Average Enrollment in Salivary Gland Cancer Trials by Year
5.2 Average Enrollment in Salivary Gland Cancer Trials by Phase
5.3 Average Enrollment in Salivary Gland Cancer Trials by Status
5.4 Average Enrollment in Salivary Gland Cancer Trials by Type of Trial

6. Companies Participating in Salivary Gland Cancer Clinical Trials
6.1 Salivary Gland Cancer Trials by Sponsor Type
6.2 Salivary Gland Cancer Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Salivary Gland Cancer Trials- Phase 1
7.2 Salivary Gland Cancer Trials- Phase 2
7.3 Salivary Gland Cancer Trials- Phase 3
7.4 Salivary Gland Cancer Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Salivary Gland Cancer Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Salivary Gland Cancer Clinical Trials and Enrolment
Figure 5: Europe - Country wise Salivary Gland Cancer Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Salivary Gland Cancer Clinical Trials and Enrolment
Figure 7: North America - Country wise Salivary Gland Cancer Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Salivary Gland Cancer Clinical Trials and Enrolment
Figure 9: Salivary Gland Cancer Clinical Trials by Phase
Figure 10: Salivary Gland Cancer Clinical Trials by Trial Status
Figure 11: Salivary Gland Cancer Clinical Trials by Type
Figure 12: Salivary Gland Cancer Clinical Trials by Sponsor Type
Figure 13: Salivary Gland Cancer Clinical Trials by Leading Sponsors
Figure 14: Salivary Gland Cancer Average Enrollment by Phase
Figure 15: Salivary Gland Cancer Average Enrollment by Trial Status
Figure 16: Salivary Gland Cancer Average Enrollment by Type
Figure 17: Salivary Gland Cancer- Average Enrolment by Type of Sponsors
Figure 18: Salivary Gland Cancer- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Salivary Gland Cancer Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Salivary Gland Cancer Clinical Trials and Enrolment
Table 5: Europe - Country wise Salivary Gland Cancer Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Salivary Gland Cancer Clinical Trials and Enrolment
Table 7: North America - Country wise Salivary Gland Cancer Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Salivary Gland Cancer Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Salivary Gland Cancer Average Enrollment by Phase
Table 15: Salivary Gland Cancer Average Enrollment by Trial Status
Table 16: Salivary Gland Cancer Average Enrollment by Type
Table 17: Salivary Gland Cancer- Average Enrolment by Type of Sponsors
Table 18: Salivary Gland Cancer- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Bayer AG
  • Bristol-Myers Squibb Co
  • Daiichi Sankyo Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Loxo Oncology Inc
  • Merck & Co Inc
  • Novartis AG
  • Pfizer Inc
Note: Product cover images may vary from those shown
Adroll
adroll